Supernus Pharmaceuticals | SUPN - Ordinary Share Capital


Supernus Pharmaceuticals reported $57.12M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
ANI Pharmaceuticals USD 22.49M 760K Dec/2025
Aurora Cannabis CAD 56.71M 134.13K Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Canopy Growth CAD 368.28M 35.9M Dec/2025
Cara Therapeutics USD 9.38M 9.38M Sep/2025
Corcept Therapeutics USD 105.97M 842K Dec/2025
Eisai JPY 282.11M 1000 Dec/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Novo Nordisk DKK 4.44B 0 Dec/2025
Pacira USD 41.12M 1.85M Dec/2025
Perrigo USD 137.6M 0 Dec/2025
Pfizer USD 5.69B 1000K Sep/2025
Supernus Pharmaceuticals USD 57.12M 1000K Sep/2025
United Therapeutics USD 43.64M 740K Dec/2025
Xeris Pharmaceuticals USD 166.22M 687.16K Dec/2025